ALHC
Alignment Healthcare LLC
8.60$
+2.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.5% | 81.7% | 82.2% | 83.6% | 82.9% | 84.6% | 86.5% | 88.0% | 89.4% | 89.3% | 90.8% | 90.7% | |
| 50.8% | 34.3% | 37.7% | 47.3% | 49.2% | 55.3% | 49.8% | 47.0% | 56.1% | 54.0% | 55.9% | 54.2% | |
| 66.9% | 53.9% | 47.6% | 50.8% | 55.0% | 60.2% | 53.5% | 50.4% | 58.4% | 56.7% | 57.6% | 54.9% | |
| 13.7% | 20.2% | 26.1% | 25.6% | 20.1% | 19.7% | 23.9% | 28.3% | 19.9% | 23.8% | 22.0% | 23.2% | |
| – | – | -63.8% | -72.9% | – | – | – | – | – | – | – | – | |
| 4.5% | 5.9% | 5.5% | 4.9% | 5.0% | 4.5% | 3.8% | 3.2% | 2.9% | 3.0% | 2.5% | 2.5% | |
| 0.7% | 0.9% | 0.8% | 0.7% | 0.7% | 0.6% | 0.5% | 0.5% | 0.4% | 0.4% | 0.4% | 0.4% | |
| 75.4% | 73.3% | 79.2% | 82.6% | 83.3% | 87.1% | 87.8% | 85.9% | 85.3% | 83.2% | 83.6% | 79.3% | |
| 53.2% | 44.4% | 52.2% | 51.9% | 51.7% | 45.0% | 51.0% | 52.9% | 55.4% | 52.2% | 57.4% | 53.4% | |
| 3.3% | 0.3% | – | – | 0.2% | 0.2% | – | – | – | 0.2% | – | – | |
| 3.3% | 28.7% | 35.4% | 34.8% | 32.6% | 31.0% | 34.5% | 36.1% | 36.9% | 39.0% | 39.2% | 32.3% | |
| 21.0% | 27.3% | 25.6% | 29.6% | 30.4% | 41.1% | 35.9% | 32.2% | 29.3% | 30.3% | 25.7% | 25.3% | |
| 24.5% | 26.5% | 20.7% | 17.3% | 16.5% | 12.8% | 12.1% | 14.1% | 14.7% | 16.8% | 16.4% | 20.7% | |
| -108.1% | -148.7% | -146.4% | -132.7% | -141.2% | -128.9% | -113.6% | -100.2% | -90.5% | -94.7% | -79.1% | -75.1% | |
| 24.3% | 31.8% | 29.8% | 26.7% | 27.6% | 24.5% | 21.6% | 20.9% | 18.9% | 18.9% | 16.9% | 16.8% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.